www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
Prioritizing flu vaccinations. Israeli health company Maccabi has partnered with Israel’s Medial EarlySign (see here). Maccabi will integrate EarlySign’s flu algorithm, which flags people at high risk of developing flu-related complications, to target them with its vaccination campaign.
https://www.calcalistech.com/ctech/articles/0,7340,L-3777715,00.html
New masks to help prevent spread of coronavirus. (TY UWI) Israel startups Sonovia (see here) and Argaman (see here) are racing to produce production versions of their bio-inhibitive and anti-viral textiles and masks. They could be vital prevention tools in epidemics like the deadly Wuhan coronavirus.
https://www.israel21c.org/new-antiviral-masks-from-israel-may-help-stop-deadly-virus/
https://www.youtube.com/watch?v=opeKFbbZxo8 http://argamantech.com/ https://vimeo.com/214152223
Another good trial of colon capsule scan. (TY Atid-EDI) Israel’s Check-Cap has announced positive results from its latest US pilot study of its C-Scan colon capsule system. The dual-center study achieved both primary (safety) and secondary (patient satisfaction and performance) endpoints. C-Scan is already CE approved.
http://ir.check-cap.com/2019-12-30-Check-Cap-Announces-Positive-Results-from-U-S-Pilot-Study-of-C-Scan-R-System
Success at Phase 3 for acne cream. (TY Atid-EDI) Following on from good Phase 2 trials (see here) Israel’s Sol-Gel reported excellent results from pivotal Phase 3 clinical trials of its Twyneo treatment of patients with acne vulgaris. The trial significantly reduced moderate-to-severe acne in 858 patients aged nine and older.
http://ir.sol-gel.com/news-releases/news-release-details/sol-gel-announces-positive-top-line-phase-3-trial-results
Treating genetic diseases. Israeli-founded Emendo Biotherapeutics, based in New York, utilizes protein engineering for precision gene editing, to treat certain genetic disorders and diseases. It has seven treatments in early stages of development. Emendo has just raised $61 million of funding.
https://www.calcalistech.com/ctech/articles/0,7340,L-3777874,00.html https://emendobio.com/
Optical discovery from shrimps. (TY WIN) Scientists at Israel’s Ben Gurion University and Weizmann Institute have discovered how shrimp can see in the murky depths of the sea. The biocrystal coating of their retina light detectors may inspire the development of new optical coatings and specialized paints.
http://www.xinhuanet.com/english/2020-01/20/c_138721546.htm
More about low-cost X-rays. As reported previously (see here), Israel’s Nanox has developed technology to lower the cost of X-ray imaging and make it more accessible to the developing world. Nanox has just received $26 million funding for its Nanox.Arc digital X-ray device and accompanying Nanox.Cloud software.
https://www.jpost.com/HEALTH-SCIENCE/Israeli-company-aims-to-make-medical-imaging-accessible-to-all-615156
A future end to dialysis. (TY UWI) Researchers at Israel’s Sheba Medical Center found that damaged kidneys can be rejuvenated by extracting healthy kidney stem cells from diseased cells, multiplying the healthy cells in a laboratory and reintroducing them into the kidney. Israel’s KidneyCure (see here) has begun human trials.
https://jewishnews.timesofisrael.com/scientists-in-israel-make-breakthrough-in-fight-against-kidney-disease/
http://www.israelnationalnews.com/News/News.aspx/275123 https://www.kidneycure.com/approach
https://www.cell.com/cell-reports/pdfExtended/S2211-1247(19)31704-8